共 50 条
- [4] Biosimilar Infliximab Switching is Not Associated with Adverse Outcomes: A Real-World Effectiveness Analyses in a National US Cohort of US Military Veterans with Inflammatory Bowel Disease JOURNAL OF CROHNS & COLITIS, 2023, 17 : 880 - 881
- [7] Infliximab Biosimilar Use for Inflammatory Bowel Disease: A National Veterans Affairs Experience AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 : S389 - S390
- [10] Multiple infliximab biosimilar switches appear to be safe and effective in a real-world inflammatory bowel disease cohort JOURNAL OF CROHNS & COLITIS, 2023, 17 : 876 - 876